From Intake to Evidence: Elmiron Eye Injury Litigation

How forward-thinking technology can help firms build stronger case inventories. Webinar presented by SimplyConvert and Pattern Data. 

smartmockups_kn4trm06

About the Webinar

Widely prescribed over decades to treat a bladder condition called interstitial cystitis, Elmiron is now linked to maculopathy and other life-altering eye injuries. It is estimated that hundreds of thousands of people have taken the drug -- the majority of whom are women.  

As firms across the country work to sign Elmiron clients, SimplyConvert and Pattern Data teamed up for a webinar on Thursday, April 29th at 2 pm ET that you don't want to miss. 

From Intake to Evidence: Elmiron Eye Injury Litigation includes insights on the litigation from leading members of the Plaintiff's Steering Committee and spotlights how firms can use forward-thinking technology to build stronger case inventories.

February 19, 2021 1 PM EST (2)The panel discusses the following: 

  • Elmiron litigation update and next steps
  • Science overview and injury profiles
  • Using AI to analyze medical data and identify case trends sooner
  • AI-powered client intake and evidence-driven refinements to case selection criteria

Speakers

Copy of Paraquat Webinar Email Header

Watch the Recording and Download the Slides 

Complete the form below to access the recorded webinar and slides.